4Dmedical stock falls 1.00 percent to AUD 3.95

Published on 10/08/2026 at 08:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

4Dmedical stock was last at AUD 3.95 on October 8, 2026, while three analysts set a Hold consensus and an AUD 4.37 average target. Its AGM is scheduled for October 28.

4Dmedical, AU0000095416, Illustration mit AI erstellt.

4Dmedical stock (ISIN AU0000095416) was last at AUD 3.95 on the ASX on October 8, 2026, down 1.00 percent from the AUD 3.99 prior close. The move leaves the medical technology company with a market capitalization of AUD 2.4 billion and gives investors a fresh measure of valuation ahead of its annual meeting.

Price stays below yearly high

The ASX quote reached AUD 4.03 and touched AUD 3.90 during the October 8 session, with volume of 2,845,624 shares. The 52-week range runs from AUD 1.40 to AUD 7.55, placing the latest price AUD 3.60 below the yearly high and AUD 2.55 above the low.

The daily comparison is clear: AUD 3.95 is AUD 0.04 below the prior close, equivalent to a 1.00 percent decline. The stock therefore remains well above its 52-week low, but it is also 47.68 percent below the high based on the quoted range.

Hold consensus meets AGM date

Stock Analysis lists a Hold consensus from three analysts as of October 6, 2026, with an average 12-month price target of AUD 4.37. The same overview reports an AUD 2.45 billion market capitalization and a 52-week price gain of 72.46 percent as of that date.

On the company calendar, 4DMedical says its 2026 annual general meeting will take place on October 28, 2026, at 10:00 a.m. AEDT. The meeting gives shareholders a dated checkpoint for board matters and the company's next phase of commercial expansion.

Imaging software drives the story

4DMedical describes its business as advanced diagnostic imaging built around XV Technology and Imbio Technology. Its non-invasive, contrast-free tools are designed to add information about lung function and respiratory conditions to existing imaging workflows.

That operating model makes commercial adoption and cash deployment central issues for the stock. The latest price action offers a measurable checkpoint: the shares were last at AUD 3.95, while the consensus target stood at AUD 4.37 on October 6, 2026.

4Dmedical stock was last at AUD 3.95

4Dmedical stock was last at AUD 3.95 on the ASX on October 8, 2026, at 4:10 p.m. AEDT. The quoted market capitalization was AUD 2.4 billion, and the 52-week range was AUD 1.40 to AUD 7.55.